Callyope vs Armilla AI
Side-by-side comparison of AI visibility scores, market position, and capabilities
Callyope (Paris, AWS Pioneers 2026) raised .41M seed with 8 clinical trials ongoing, using speech AI to detect psychiatric deterioration early and deliver objective data between visits.
About
Callyope is a Paris-based clinical AI company founded to improve outcomes in mental health through passive, continuous monitoring. The company applies speech analysis and machine learning to detect early signals of psychiatric deterioration, enabling clinicians to intervene before crises occur. Its core technology processes vocal biomarkers to track mood, cognition, and behavioral patterns over time without requiring patients to self-report symptoms.\n\nCallyope's platform is designed for integration within clinical workflows, targeting psychiatrists, mental health hospitals, and digital health providers. The product supports remote patient monitoring between visits, generating objective data streams that augment clinician judgment. Unlike consumer wellness apps, Callyope operates within regulated clinical environments and is built to meet the evidentiary standards required for reimbursement and adoption in European and US health systems.\n\nThe company raised a $2.41 million seed round to fund product development and clinical validation. It currently has eight clinical trials ongoing and was selected for the AWS Healthcare Accelerator Pioneers 2026 cohort, reflecting recognition of its technical and scientific rigor. Callyope's pipeline of trial data positions it to pursue regulatory clearance and reimbursement pathways, which would unlock hospital procurement and enterprise mental health contracts at scale.
AI quality assurance with insurance-backed warranties from Swiss Re and Greenlight Re; EU AI Act compliance assessments backed by YC and reinsurance partners for high-risk AI deployments.
About
Armilla AI is a third-party AI quality assurance and warranty company that evaluates AI models for organizations deploying AI in regulated or high-stakes contexts — assessing models against EU AI Act and NIST AI Risk Management Framework requirements for risks including bias, hallucination, robustness failures, and adversarial vulnerabilities, then providing performance guarantees backed by insurance coverage from reinsurers Swiss Re, Greenlight Re, and Chaucer. Founded in Toronto, Canada, Armilla raised $6.81 million total including a C$4.5 million seed round in February 2024 from Mistral Venture Partners, MS&AD Ventures, Y Combinator, and its reinsurance partners.\n\nArmilla's model is unique in the AI governance market — rather than just providing compliance reports, Armilla backs its assessments with insurance warranty products. An enterprise deploying a third-party AI model can purchase an Armilla warranty that pays out if the model performs differently than assessed (fails on bias, accuracy, or robustness metrics), transferring AI performance risk to insurance markets that can price and distribute it. This insurance mechanism creates financial accountability for AI quality claims that audit reports alone don't provide.\n\nIn 2025, Armilla competes in the AI governance, risk, and compliance market with Credo AI, Arthur AI, and AI audit firms for enterprise AI risk assessment and compliance tools. The EU AI Act, fully applicable by August 2025 for high-risk AI systems, is driving enterprise compliance urgency — companies deploying AI in hiring, credit scoring, healthcare, and other regulated contexts need third-party conformity assessments. Armilla's insurance-backed warranty differentiates its offering from pure advisory competitors. The reinsurer backing (Swiss Re, Greenlight Re, Chaucer) provides both capital credibility and distribution through insurance broker channels. The 2025 strategy focuses on growing EU AI Act compliance assessments and expanding the warranty product coverage to more AI deployment use cases.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.